Cha Gi Doo, Jung Sonwoo, Choi Seung Hong, Kim Dae-Hyeong
Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, Korea.
School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul, Korea.
Brain Tumor Res Treat. 2022 Jul;10(3):151-157. doi: 10.14791/btrt.2022.0017.
Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the limited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. Therefore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of chemotherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM.
多形性胶质母细胞瘤(GBM)是一种以恶性程度高而臭名昭著的脑肿瘤。标准治疗疗效有限的关键原因是GBM的高复发率,即使在手术切除后也是如此。因此,术后通常会进行强化化学疗法,例如全身递送各种药物和/或药物组合。然而,通过全身给药克服血脑屏障以有效地将药物递送至脑肿瘤仍然是一个艰巨的目标。因此,已经提出了各种显示出提高治疗效果潜力的局部给药方法。特别是,最近将电子设备用于向GBM组织控释化疗药物的应用引起了关注。我们在此回顾了局部给药策略(包括电子辅助策略)在研究和商业层面的最新进展。我们还简要讨论了GBM局部化疗方法尚未解决的挑战和未来的研究方向。